Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Indiana University (IU) scientists specializing in optometry and artificial intelligence have received support from the ...

Late-breaking oral presentation to highlight safety and efficacy of LX1001 across four dose cohorts NEW YORK, Oct. 22, 2024 ...

A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...

The Permian Basin's Walk to End Alzheimer's is coming up Oct. 26. The event opens at 9 a.m. at Scharbauer Sports Complex-Coterra Pavilion, 5514 Champions Drive, in Midland. The opening ceremony is at ...

On Oct. 5, Rancho Santa Fe’s charity group The Frostys served as the entertainment along the route of the Alzheimer’s ...

Sage is lopping off one-third of its workforce after one of its experimental drugs failed to prove effective as a treatment ...

MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

Utilising genetic information responsibly allows people to understand the uncertain waters of Alzheimer's with both knowledge and hope; ready to confront challenges together. Here’s why genetic testin ...